If the cathepsin-mediated endocytosis pathway can also be used for SARS-CoV-2 infection in Calu-3 cells, then a certain level of viral infection should be observed even when TMPRSS2 activity is inhibited by nafamostat. Here, CTSS is linked to viral infectious disease.